Neoadjuvant therapies for hepatocellular
โ
Patricia M. Lopez; Augusto Villanueva; Sasan Roayaie; Josep M. Llovet
๐
Article
๐
2006
๐
John Wiley and Sons
๐
English
โ 133 KB
Hepatocellular carcinoma (HCC) is a major health problem, being the fifth most common cancer worldwide. 1 The incidence of HCC is increasing in Europe and the United States, 2 and it is currently the leading cause of death among patients with cirrhosis. 3 The advent of surveillance programs has led